Abstracts Archive - Page 922 of 2425 - ACR Meeting Abstracts

Abstract Number: 2455 • 2019 ACR/ARP Annual Meeting
Impact of Enthesitis on Patient Reported Outcomes and Physician Satisfaction with Treatment: Data from a Multinational Patient and Physician Survey
Ana-Maria Orbai¹, Birt Julie ², Elizabeth Holdsworth ³, Nicola Booth ⁴, Matthew M. Hufford ², Malatestinic William ², Aubrey Trevelin Sprabery ² and Anthony Reginato ⁵, ¹Johns Hopkins University School of Medicine, Baltimore, MD, ²Eli Lilly and Company, Indianapolis, IN, ³Adelphi Real World, Manchester, England, United Kingdom, ⁴Adelphi Real World, Bollington, United Kingdom, ⁵Division of Rheumatology, Providence VAMC, Associate Professor in Medicine, The Warren Alpert School of Medicine, Providence
Background/Purpose: Enthesitis, a characteristic clinical feature of psoriatic arthritis (PsA) [1], is a core outcome for PsA clinical trials. While enthesitis is considered important when…
Abstract Number: 2456 • 2019 ACR/ARP Annual Meeting
Validity of Patient-reported Cardiovascular Events in a Large Longitudinal Cohort of Patients with Psoriatic Arthritis and Psoriasis
Keith Colaco¹, Vinod Chandran ², Dafna Gladman ³ and Lihi Eder ⁴, ¹University of Toronto, Women's College Hospital, University Health Network, Toronto, ON, Canada, ²University Health Network, University of Toronto, Toronto, Canada, ³Toronto Western Hospital, Toronto, Canada, Toronto, ON, Canada, ⁴Women’s College Hospital and the Department of Medicine, University of Toronto, Toronto, Canada
Background/Purpose: Valuable information on cardiovascular disease outcomes can be obtained from large cohort studies. Such studies often rely on self-reported events, which are best validated…
Abstract Number: 2457 • 2019 ACR/ARP Annual Meeting
Increased Prevalence of Systemic Lupus Erythematosus Co-morbidity in Patients with Psoriatic Arthritis: A Population-Based Case-Controlled Study
Danielle Korkus ¹, Tal Gazitt ², Arnon Dov Cohen ³, Ilan Feldhamer ⁴, Idit Lavi ², Amir Haddad ², Sari Greenberg-Dotan ⁴, Erez Batat ⁴ and Devy Zisman⁵, ¹The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel, ²Carmel Hospital, Haifa, Israel, ³Central Headquarters, Clalit Health Services,Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheba, Israel, Tel Aviv, Israel, ⁴Central Headquarters, Clalit Health Services, Tel Aviv, Israel, ⁵Carmel Hospital and Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel, Haifa, Israel
Background/Purpose: Patients with psoriasis and psoriatic arthritis (PsA) can develop a variety of comorbidities which may influence the therapeutic regimen and affect treatment results. Previous…
Abstract Number: 2458 • 2019 ACR/ARP Annual Meeting
Predictors of Structural Progression in Psoriatic Arthritis: Clinical versus Systemic Inflammation
Carina Borst¹, Farideh Alasti ² and Daniel Aletaha ³, ¹Division of Rheumatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria, ²Medical University of Vienna, Department of Medicine III, Division of Rheumatology, Vienna, Austria, ³Medical University of Vienna, Vienna, Austria
Background/Purpose: Psoriatic arthritis (PsA) belongs to the group of the spondylarthropathies. It is associated with psoriasis and typically seronegative for autoantibodies. PsA disease activity can…
Abstract Number: 2459 • 2019 ACR/ARP Annual Meeting
Effect of Obesity and Surgical Weight Loss on Joint Surgery Hospitalizations in Psoriatic Arthritis: Data from National Inpatient Sample
Rashmi Dhital¹, Dilli Ram Poudel ², Anthony Donato ³, Olubunmi Oladunjoye ⁴ and Paras Karmacharya ⁵, ¹Reading Hospital ,PA, Shillington, PA, ²University of Pennsylvania, Philadelphia, ³Reading Hospital, PA, Reading, ⁴Reading Hospital, PA, West Reading, PA, ⁵Reading Hospital, Mayo Clinic, Rochester
Background/Purpose: Obesity is associated with higher disease activity and poor treatment response in patients with psoriatic arthritis (PsA). However, there is limited data as to…
Abstract Number: 2460 • 2019 ACR/ARP Annual Meeting
Frailty in Ankylosing Spondylitis, Psoriatic Arthritis, and Rheumatoid Arthritis: Data from a National Claims Database
Sarah Lieber¹, Mangala Rajan ², Sebastian E. Sattui ¹, Geyanne Lui ³, Sergio Schwartzman ⁴, Lisa Mandl ⁴ and Iris Navarro-Millan ², ¹Hospital for Special Surgery, New York, ²Weill Cornell Medicine, New York, ³Weill-Cornell Medicine, New York, NY, ⁴Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, New York, NY
Background/Purpose: Frailty, a state of decreased homeostatic reserve, is associated with increased disability and mortality, independent of age. Frailty has been evaluated in large datasets…
Abstract Number: 2461 • 2019 ACR/ARP Annual Meeting
Clinical Presentation and Treatment of Oligoarticular Psoriatic Arthritis in Canada: High Frequency of Smaller Joint Involvement
Alfred Cividino¹, Denise Nicholson ², Sherif Guindi ², Jennifer Jelley ², Anne-Julie Gaudreau ² and Dafna Gladman ³, ¹McMaster University's Faculty of Health Sciences, Hamilton, ON, Canada, ²Celgene Corporation, Summit, NJ, ³University of Toronto, Toronto, ON, Canada
Background/Purpose: Oligoarticular disease in patients with psoriatic arthritis (PsA) is often underdiagnosed and undertreated. The goal of this study is to understand and identify current…
Abstract Number: 2462 • 2019 ACR/ARP Annual Meeting
Use of Complementary and Alternative Medicine (CAM) in a Psoriatic Arthritis Cohort
John Roberts IV ¹, Lisa Mandl ², Zafir Abutalib ¹ and Sergio Schwartzman², ¹Hospital for Special Surgery, New York, NY, New York, NY, ²Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, New York, NY
Background/Purpose: Approximately one third of people in the United States use complementary and alternative medicines. While there is published data on the use of CAM…
Abstract Number: 2463 • 2019 ACR/ARP Annual Meeting
Body Composition and Fat Distribution in Patients with Psoriasis or Psoriatic Arthritis
Eric Toussirot¹, Francois Aubin ¹, maxime Desmarets ¹, Daniel WENDLING ², benoit Augé ³, jerome Gillard ⁴, olivier messica ⁴, Xavier Guillot ¹, caroline Laheurte ⁵, elisabeth monnet ¹ and gilles dumoulin ¹, ¹University Hospital, Besancon, France, ²Rheumatology, University Teaching Hospital (CHRU), Besançon, France, ³private office, besancon, France, ⁴Centre Hospitalier, Lons le Saunier, France, ⁵EFS, besancon, France
Background/Purpose: Obesity is a leading comorbidity in both psoriasis (Pso) and psoriatic arthritis (PsA) and is associated with common metabolic complications and increased cardiovascular (CV)…
Abstract Number: 2464 • 2019 ACR/ARP Annual Meeting
Multidisciplinary Unit of Psoriatic Arthritis: Clinical Results
Clara Pérez-Velásquez¹, Oihane Ibarguengoitia-Barrena ², David Montero-Seisdedos ², Lucía Vega-Alvarez ², Carmen García-Gómez ¹, Eva Galindez-Agirregoikoa ³, Silvia Pérez-Barrio ⁴, María Esther Ruiz-Lucea ², Ignacio Torre-Salaberri ², Ana Rosa Intxaurbe-Pellejero ², Olaia Fernandez-Berrizbeitia ¹, Juan María Blanco-Madrigal ², Eduardo Cuende-Quintana ², Itziar Calvo-Zorrilla ², Iñigo Gorostiza-Hormaeche ⁵, Natalia Andrea Rivera-García ², María Jesus Allande-López-Linares ², Helena Ugarte-Zuazo ² and María García-Vivar ¹, ¹University Hospital of Basurto, Bilbao, Pais Vasco, Spain, ²Rheumatology Unit, Basurto University Hospital, Bilbao, Spain, Bilbao, Spain, ³Hospital de Basurto, Bilbao, Pais Vasco, Spain, ⁴University Hospital of Basurto, Dermatology Department, Bilbao, Pais Vasco, Spain, ⁵Investigation Unit, Basurto University Hospital, Bilbao, Spain, Bilbao, Spain
Background/Purpose: The multidisciplinary unit of psoriatic arthritis (PsA) are attractive to improve the early diagnosis and optimize the management of complex patients with PsA. There…
Abstract Number: 2465 • 2019 ACR/ARP Annual Meeting
Reliability and Validity of the Self‐Administered Comorbidity Questionnaire in Psoriatic Arthritis
Didem Erdem¹, Halise Hande Gezer ², Sevtap Acer Kasman ¹ and Mehmet Tuncay Duruoz ¹, ¹Marmara University School of Medicine, PMR Department, Rheumatology Division, İstanbul, Turkey, ²Marmara University School of Medicine, PMR Department, Rheumatology Division, İstanbul, Istanbul, Turkey
Background/Purpose: The Self‐Administered Comorbidity Questionnaire (SCQ) is a self-report questionnaire. It assesses 13 common medical conditions and the impact of comorbidities on functional status (1).…
Abstract Number: 2466 • 2019 ACR/ARP Annual Meeting
Evolution of Health-Related Quality of Life in Psoriatic Arthritis Patients
Dalifer Freites Nuñez¹, Leticia León ², Pia Lois ³, Alfredo Madrid García ⁴, Judit Font Urgelles ⁵, Cristina Vadillo Font ⁶, lydia Abasolo Alcazar ⁶, Juan Angel Jover Jover ⁶, Benjamín Fernández Gutiérrez ⁷ and Luis Rodríguez-Rodríguez ⁴, ¹Hospital Clínico San Carlos, MADRID, Spain, ²Fundación para la Investigación Biomedica, Madrid, Madrid, Spain, ³Hospital Clínico San Carlos, Madrid, Madrid, Spain, ⁴Fundación para la Investigación Biomedica, Madrid, Spain, ⁵HOSPITAL CLINICO SAN CARLOS, MADRID, Madrid, Spain, ⁶HOSPITAL CLINICO SAN CARLOS, MADRID, Spain, ⁷Hospital Clínico San Carlos, Madrid
Background/Purpose: Psoriatic arthritis (PsA) is consider a multifaceted disease, with patients reporting lower health-related quality of life (HRQoL). Data of burden of disease is substantial…
Abstract Number: 2467 • 2019 ACR/ARP Annual Meeting
Pain and Anxiety Are Independent Factors Associated to Sleep Impairment in Psoriatic Arthritis: A Multicentric Study in 14 Countries
Penelope Palominos¹, Laura Coates ², Charles Kohem ³, Ana-Maria Orbai ⁴, Josef Smolen ⁵, Maarten de Wit ⁶, Uta Kiltz ⁷, Ying-Ying Leung ⁸, Juan Cañete ⁹, Rossana Scrivo ¹⁰, Andra Balanescu ¹¹, Emmanuelle Dernis ¹², Sandra Talli ¹³, Martin SOUBRIER ¹⁴, Sibel Zehra Aydin ¹⁵, Inna Gaydukova ¹⁶, Umut Kalyoncu ¹⁷ and Laure Gossec ¹⁸, ¹Serviço de Reumatologia, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul,, Porto Alegra, Brazil, ²University of Oxford, Oxford, United Kingdom, ³Serviço de Reumatologia, Hospital de Clinicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil, ⁴Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, Baltimore Maryland, ⁵Medical University of Vienna, Vienna, Austria, ⁶Department of Medical Humanities, Amsterdam Public Health (APH), Amsterdam University Medical Centre, Amsterdam, Netherlands, ⁷Rheumazentrum Ruhrgebiet/Ruhr University Bochum, Herne, Germany, Herne, Germany, ⁸Department of Rheumatology and Immunology, Singapore General Hospital,, Singapore, Singapore, ⁹Department of Rheumatology, Hospital Clínic, Barcelona, Barcelona, Spain, ¹⁰Rheumatology Unit, Department of Internal Medicine and Medical Specialties, Sapienza Università di Roma,, Rome, Italy, ¹¹Sf Maria Hospital, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania, ¹²Rheumatology Department, Le Mans Central Hospital, Le Mans, France, ¹³Rheumatology Department, East-Tallinn Central Hospital, Tallinn, Estonia, ¹⁴CHU Gabriel Montpied, Clermont Ferrand, Auvergne, France, ¹⁵University of Ottawa Faculty of Medicine, Rheumatology,Ottawa Hospital Research Institute, 1967 Riverside Drive, Ottawa, ON, K1H 7W9, CANADA, Ottawa, Canada, ¹⁶North-western State medical university, St Petersburg, Russia, ¹⁷Hacettepe University Department of Rheumatology, Ankara, Turkey, ¹⁸Sorbonne Université and Hôpital Pitié-Salpêtrière, Paris, France
Background/Purpose: Sleep quality is diminished in patients with psoriatic arthritis (PsA) and close to 40% of PsA patients consider sleep impairment a priority domain.This work…
Abstract Number: 2468 • 2019 ACR/ARP Annual Meeting
JAK-STAT Signaling System in Pannus Formation of Psoriatic Arthritis: A Therapeutic Target
Siba Raychaudhuri¹ and Smritikana Raychaudhuri ², ¹UC Davis School of Medicine, Sacramento, CA, ²UC Davis School of Medicine, Davis, CA
Background/Purpose: Psoriatic arthritis (PsA) involves inflammation of the joint synovium where synovial cells (FLS) are the target for T cell activated cytokines for pannus formation.…
Abstract Number: 2469 • 2019 ACR/ARP Annual Meeting
Diversity of Poly-Functional T Cells in Psoriatic Arthritis and Rheumatoid Arthritis and Its Therapeutic Significance
Siba Raychaudhuri¹ and Smritikana Raychaudhuri ², ¹UC Davis School of Medicine, Sacramento, CA, ²UC Davis School of Medicine, Davis, CA
Background/Purpose: Importance to specific T cell subpopulations has been attributed for specific diseases such as Th17 cells in psoriatic disease, Th1 cells in TB and…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].